Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting-edge treatments for cancer.
18 employees · est. 2020 · San Diego, United States
Himuka AM Pharma / Himuka AM Australia
Himuka is a clinical-stage biotech company, and conducting a Phase 1 clinical trial in Australia.
1 employees · est. 2017 · Miyazaki, Japan
Himuka AM Pharma / Himuka AM Australia is the older company (2020 vs 2017); Antharis Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Antharis Therapeutics, Inc. | Himuka AM Pharma / Himuka AM Australia |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2017 older |
| Headquarters | ||
| Headquarters | San Diego, United States | Miyazaki, Japan |
| Employees | ||
| Employees | 18 larger | 1 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health and Wellness | Digital Health, Health Care, Medical Devices |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Corporate Round |
| Total Funding | ||
| Total Funding | Not tracked yet | $600.00M |
| Funding Rounds | ||
| Funding Rounds | Not tracked yet | 3 |
| Services | ||
| Services | Developing Transformative Medicines, Therapies Harnessing the Immune System, Cutting-edge Biomedical Research, Therapeutically-relevant Antibody Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Professionals, Patients with Unmet Medical Needs, Cancer Patients, Medical Institutions, Biotech and Pharmaceutical Partners | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Cancer Treatment, Monoclonal Antibodies, Antibody-drug Conjugates, Oncology, Therapeutic Antibodies, Inflammatory Diseases, Innovative Therapies, Biotech Acquisitions, Clinical Trials, Transformational Therapies, Unmet Medical Needs, Pioneering Research, Solid Tumor Therapy, Bispecific Antibodies | Biotech, Clinical-stage Company, Phase 1 Clinical Trial, Australia, Novel Therapies, Unmet Medical Needs, HM201, Adrenomedullin, Peptide Drug Candidate, Inflammatory Bowel Disease, Pharmaceutical Company, Drug Development, Bioactive Peptide, University Of Miyazaki |
| Website | ||
| Website | antharistherapeutics.com | himuka-am.com |
About Antharis Therapeutics, Inc.
Antharis Therapeutics, Inc., founded in 2020 by Dr. Raphael R Pinaud, is a multinational biopharmaceutical company headquartered in the United States. Specializing in cancer and inflammatory disease treatments, it employs cutting-edge science to create next-generation monoclonal antibodies and antib...
About Himuka AM Pharma / Himuka AM Australia
Himuka AM Pharma / Himuka AM Australia Himuka is a clinical-stage biotech company engaged in the research and development of novel therapies for unmet medical needs. Established in 2017 and headquartered in Japan, the company is currently conducting a Phase 1 clinical trial in Australia. Himuka's pr...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Antharis Therapeutics, Inc. and Himuka AM Pharma / Himuka AM Australia — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Antharis Therapeutics,... and Himuka AM Pharma / Him... — by email.
Frequently Asked Questions
Compare Antharis Therapeutics, Inc. with someone else
Start typing a company name or domain.